HomeTLSI • NASDAQ
add
TriSalus Life Sciences Inc
Previous close
$4.32
Day range
$4.15 - $4.36
Year range
$3.61 - $10.32
Market cap
135.26M USD
Avg Volume
29.32K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 7.35M | 41.52% |
Operating expense | 13.34M | -29.38% |
Net income | -2.40M | -68.35% |
Net profit margin | -32.64 | -18.95% |
Earnings per share | -0.40 | — |
EBITDA | -6.83M | 51.69% |
Effective tax rate | 0.12% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 11.29M | -47.21% |
Total assets | 27.48M | -18.11% |
Total liabilities | 47.91M | 91.14% |
Total equity | -20.43M | — |
Shares outstanding | 30.49M | — |
Price to book | -6.45 | — |
Return on assets | -58.40% | — |
Return on capital | -2,146.32% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -2.40M | -68.35% |
Cash from operations | -10.85M | 49.93% |
Cash from investing | -169.00K | 84.80% |
Cash from financing | 5.82M | -85.53% |
Net change in cash | -5.19M | -129.71% |
Free cash flow | -8.00M | 74.15% |
About
Founded
2009
Headquarters
Website
Employees
116
